Thyroxine replacement requirements in hypothyroid patients receiving phenytoin
Blackshear, J.L.; Schultz, A.L.; Napier, J.S.; Stuart, D.D.
Annals of Internal Medicine 99(3): 341-342
1983
ISSN/ISBN: 0003-4819 PMID: 6614682 Document Number: 206265
Document emailed within 1 workday
Related Documents
Deam, D.R.; Campbell, D.G.; Ratnaike, S. 1983: Effect of oral intake of thyroxine on results of thyroid function tests in patients receiving thyroid replacement therapy Medical Journal of Australia 2(8): 374-376Xiang, G-da.; Sun, H-ling.; Zhao, L-shuang.; Hou, J.; Yue, L. 2007: Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients Zhonghua Yi Xue Za Zhi 87(30): 2121-2125
Kariks, J.; Perry, S.W.; Wood, D. 1971: Serum folic acid and phenytoin levels in permanently hospitalized epileptic patients receiving anticonvulsant drug therapy Medical Journal of Australia 2(7): 368-371
Li, J-hua.; Zhang, R.; Wang, B-lei.; Na, R.; Li, Y.; Zhao, X-juan.; Liang, D-chun.; Guo, G. 2010: Effects of supplement of thyroxine for hypothyroid pregnant rat on the expression of homeobox gene Nkx2.1 mRNA in the offspring's cerebrum tissue Zhonghua Yu Fang Yi Xue Za Zhi 44(8): 726-730
Xing, H.; Shen, Y.; Chen, H.; Wang, Y.; Shen, W. 2001: Heart rate variability and its response to thyroxine replacement therapy in patients with hypothyroidism Chinese Medical Journal 114(9): 906-908
Dubuis, J.M.; Sanchez-Menegay, C.; Burger, A.G. 1992: Effects of thyroxine, triiodothyronine and reverse triiodothyronine on the neonatal hypothyroid rat cerebellum Acta Medica Austriaca 19(Suppl 1): 106-109
van Doorn, J.; Roelfsema, F.; van der Heide, D. 1982: Contribution fron local conversion of thyroxine to 3,5,3'-triiodothyronine to intracellular 3,5,3'-triiodothyronine in several organs in hypothyroid rats at isotope equilibrium Acta Endocrinologica 101(3): 386-396
Schrander-v d Meer, A.M.; van Saase, J.L.; Roodvoets, A.P.; van Dorp, W.T. 1995: Mortality in patients receiving renal replacement therapy, a single center study Clinical Nephrology 43(3): 174-179
Wierzchowiecki, M.; Swiderczuk, A.; Dyderski, S.; Masiakowski, J.; Jazienicki, B. 1987: Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders Kardiologia Polska 30(9): 577-582
Rootwelt, K. 1971: Thyroxine iodine in the blood. Evaluation of the diagnostic possibilities of serum thyroxine determined by competitive radioimmunoassay, along with serum thyroxine determination combined with the triiodothyronine test and estimation of the free thyroxine factor Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(21): 1534-1538
Van Campenhout, J.; Choquette, P.; Vauclair, R. 1980: Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving estrogen replacement therapy Obstetrics and Gynecology 56(3): 349-355
Wilson, L.; Sheehan, J.; Thorpe, M. 2013: Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy Irish Medical Journal 106(1): 24-25
Kosturkov, G.; Bozhkov, B.; Dimitrov, V. 1984: Serum thyroxine (T4) levels and thyroxine-binding capacity of patients with corticosteroid-dependent and atopic bronchial asthma Vutreshni Bolesti 23(4): 69-72
Passath, A. 1989: The role of binding proteins in radioimmunologic determination of the free thyroxine concentration using thyroxine analog methods: thyroxine immunoextraction versus thyroxine analog immunoextraction Wiener Medizinische Wochenschrift 139(5): 98-102
Halawa, B.; Mazurek, W. 1979: Serum levels of thyrotropin triiodothyronine, thyroxine and thyroxine-binding proteins in patients with coronary disease and hyperlipoproteinemia of the IIA and IIB types Wiadomosci Lekarskie 32(10): 677-680
Burnett, J.R.; Cooke, R.; Crooke, M.J.; Feek, C.M. 1992: A study of L-thyroxine replacement New Zealand Medical Journal 105(930): 105-106
Howorth, P.J.; McKerron, C.G.; Marsden, P. 1975: Evaluation of a kit (Thyrolute) for the combined determination of serum total thyroxine and sequential free thyroxine index using Sephadex G-25 and 125I-thyroxine Annals of Clinical Biochemistry 12(5): 200-206
Yu, H-Yu.; Liu, C-Ho.; Chen, Y-Sharng.; Wang, S-Shen.; Chu, S-Hsun.; Lin, F-Yue. 2005: Relationship of international normalized ratio to bleeding and thromboembolism rates in Taiwanese patients receiving vitamin K antagonist after mechanical valve replacement Journal of the Formosan Medical Association 104(4): 236-243
Levine, M.N.; Planes, A.; Hirsh, J.; Goodyear, M.; Vochelle, N.; Gent, M. 1989: The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement Thrombosis and Haemostasis 62(3): 940-944
Rudolf, K.; Rudolf, H.; Rüting, M.; Falkenhagen, D. 1988: Behavior of the basal and stimulated serum level of thyroid stimulating hormone and determination of thyroxine, thyroxine- binding capacity and free thyroxine index in females with chronic uremia Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 43(20): 590-592